| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |